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Background
Efforts are underway to perform MRI-guided cardiac
ablations in the magnet. The chief motivations are: 1)
the ability to see the effects of treatment, 2) improved
catheter positioning during mapping and therapy, and 3)
avoiding ionizing radiation and iodinated contrast agent
from x-ray.
However, current efforts use gadolinium-based con-
trast agents (GBCAs) to obtain MR Angiogram (MRA)
for anatomical context and late gadolinium enhance-
ment (LGE) for enhancement of ablation lesions. There
may be motivations to limit use of GBCAs, both in the
specific context of an ablation procedure and in general
use. The general use motivation is health-based, as the
FDA is investigating the risk of gadolinium deposits in
the brain after repeated use of GBCAs.
Another motivation is for accuracy in assessment of
acute lesions, since wash-in/out kinetics make it difficult
to infer lesion size from enhancement regions in LGE
images, even with carefully chosen timing and imaging
parameters. The typical LGE protocol requires waiting
10-15 minutes after contrast agent injection before T1w
imaging. This protocol is both unpractical to run repeat-
edly and limited by contrast-agent dose.
It may be possible to perform this procedure without
GBCAs. We focus on the acquisition of images for MRA,
real-time navigation and lesion assessment. We present
proof-of-concept data in swine left ventricle (LV).
Methods
Healthy swine were placed in 1.5T MRI (Avanto, Siemens
Medical Systems) and bright-blood whole-heart images
were acquired using 3D navigator-gated TrueFISP, to
serve as surrogate for MRA. Image window/level modifi-
cation and clipping were used to suppress or remove
background.
Ablations were performed using MR compatible
catheters, navigating in the LV using real-time MRI.
T1w images were acquired early after ablation.
3D TrueFISP was acquired with navigator-gating, voxel
0.6x0.6x3. For T1w: navigator-gating, voxel 0.7x0.7x2.5,
flip=20, saturation prep, TR/TE/TI=498/1.4/440.
Results
A MIP rendering of an example bright-blood 3D True-
FISP image set is shown in Figure 1. The isolation of
blood regions is inferior to that of typical contrast-
enhanced MRA; however, it provided sufficient context
while navigating in the LV when used together with
real-time imaging.
Figure 2 shows a T1w image acquired 5 minutes after
ablation. The lesion enhancement is readily seen in the
LV wall.
Conclusions
MRI-guided cardiac ablations in the LV may be possible
without the use of any contrast agent. In the LV, 3D
TrueFISP can be used as an MRA surrogate and lesions
exhibit enhancement in T1w images soon after the
ablation.
A non-contrast protocol may be beneficial, considering
possible health effects of accumulated gadolinium and
complications from wash-in/out kinetics on LGE image
contrast. The non-contrast T1w images may be acquired
many times during a procedure, and may assist in deter-
mining when a procedure is complete. This may have
greater utility than an LGE scan, which can be performed
only once or twice during a procedure.
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Figure 1 3D TrueFISP image stack rendered as a MIP.
Figure 2 T1w image acquired 5 minutes after ablation.
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